WATCHMAN® and WATCHMAN FLX® Left Atrial Appendage Closure Implant
For patients with atrial fibrillation (AFib) who are at risk for stroke but cannot take blood thinners, the WATCHMAN® and WATCHMAN FLX® Left Atrial Appendage Closure implants provide an effective alternative to help reduce the risk of AFib-related stroke.
State's First and Most Experienced in WATCHMAN Procedures
The WVU Heart and Vascular Institute was the first in West Virginia to perform the WATCHMAN Left Atrial Appendage Closure Implant. Since then, our team has successfully completed over 500 procedures, making us the most experienced center in the state for this life-saving treatment
Leading Comprehensive Care for Atrial Fibrillation (AFib)
The WVU Heart & Vascular Institute is recognized nationally as one of the top programs for comprehensive atrial fibrillation (AFib) management. The WVU Medicine Center for Atrial Fibrillation is West Virginia’s only program with truly dedicated multidisciplinary expertise, bringing together electrophysiologists, cardiologists, and heart surgeons who work collaboratively to provide advanced, personalized care for patients with AFib.
Our team of experts are procedural leaders in the use of cutting-edge AFib therapies, including novel devices such as the WATCHMAN® and WATCHMAN FLX® Left Atrial Appendage Closure Implants, offering safe and effective alternatives to reduce the risk of AFib-related stroke.
About WATCHMAN®
WATCHMAN® and WATCHMAN FLX® Left Atrial Appendage Closure Implants
For patients with atrial fibrillation (AFib) who are at risk for stroke but cannot take blood thinners, the WATCHMAN® and WATCHMAN FLX® Left Atrial Appendage (LAA) Closure implants offer a safe and effective alternative to reduce stroke risk.
This next-generation, minimally invasive procedure is designed to treat patients safely and efficiently, providing long-term protection against AFib-related stroke. As a relatively new and innovative option for patients with non-valvular atrial fibrillation, WATCHMAN technology gives patients who previously had limited options a way to reduce stroke risk without lifelong blood-thinning medications.
The device works by closing off the left atrial appendage (LAA), a small area of the heart where harmful blood clots can form. By sealing the LAA, WATCHMAN helps prevent clots from entering the bloodstream and causing a stroke. Over time, many patients are able to stop taking blood-thinning medications.
WATCHMAN has been successfully implanted in over 100,000 patients worldwide. It is a one-time, permanent device that does not need to be replaced and is completely internal, with no visible components outside the body.
For expert diagnosis and advanced treatment of AFib, choose West Virginia’s most trusted and proven leader.